{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:08:26Z","timestamp":1748923706064,"version":"3.41.0"},"reference-count":35,"publisher":"Consilium Medicum","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/terarkh201587462-68","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T15:31:49Z","timestamp":1460647909000},"page":"62","source":"Crossref","is-referenced-by-count":2,"title":["Treatment for knee osteoarthritis in patients with oxalate nephropathy"],"prefix":"10.26442","volume":"87","author":[{"given":"N. V.","family":"Voronina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. P.","family":"Slutskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. I.","family":"Markina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Kovalskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. B.","family":"Agievich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. D.","family":"Gelmutdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Bushina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201587462-68-1","unstructured":"Alekseeva L.I., Sharapova E.P. Kombinirovannye preparaty zamedlennogo deistviya v terapii osteoartroza. Rus med zhurn 2009; 3: 160\u2014164."},{"key":"key-10.17116\/terarkh201587462-68-2","doi-asserted-by":"crossref","unstructured":"Matel-Pelletier J., Pelletier J.P. Effects of Diacerein at the molecular level in the Osteoarthritis Disease Process. Ther Adv Musculoskelet Dis 2010; 2 (2): 95\u2014104.","DOI":"10.1177\/1759720X09359104"},{"key":"key-10.17116\/terarkh201587462-68-3","unstructured":"Chichasova N.V. Lechenie osteoartroza: vliyanie na khryashchevuyu tkan' razlichnykh protivovospalitel'nykh preparatov. Rus med zhurn 2013; 3: 3\u20146."},{"key":"key-10.17116\/terarkh201587462-68-4","unstructured":"Alekseeva L.I., Sharapova E.P., Taskina E.A., Chichasova N.V., Imametdinova G.R., Shostak N.A., Pravdyuk N.G., Denisov L.N. Mnogotsentrovoe slepoe randomizirovannoe platsebo kontroliruemoe issledovanie simptom- i strukturno-modifitsiruyushchego deistviya preparata Alflutop u bol'nykh osteoartrozom kolennykh sustavov. Soobshchenie 1. Nauchno-praktich revmatologiya 2013; 5: 1\u20148."},{"key":"key-10.17116\/terarkh201587462-68-5","unstructured":"Martel-Pelletier J., Mineau F., Jolicoeur F.C., Cloutier J.M., Pelletier J.P. In vitro effects of Diacerhein and Rhein on IL-1 and TNF-a systems in human osteoarthritis synovium and chondrocytes. J Rheumatol 1998; 25: 753\u2014762."},{"key":"key-10.17116\/terarkh201587462-68-6","doi-asserted-by":"crossref","unstructured":"Yaron M., Shirazi I., Yaron I. Anti-interleukin-1 effects of Diacerhein and Rhein in human osteoarthritis synovial tissue and cartilage cultures. Osteoarthritis Cartilage 1999; 7 (3): 272\u2014280.","DOI":"10.1053\/joca.1998.0201"},{"key":"key-10.17116\/terarkh201587462-68-7","doi-asserted-by":"crossref","unstructured":"Mendes A.F., Caramona M.M., de Carvalho A.P., Lopes MC. Diacerhein and Rhein prevent interleukin-1 b- induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alfa. Pharmacol Toxicol 2002; 91: 22\u201428.","DOI":"10.1034\/j.1600-0773.2002.910104.x"},{"key":"key-10.17116\/terarkh201587462-68-8","doi-asserted-by":"crossref","unstructured":"Martin G., Bogdanowicz P., Domagala F., Ficheux H., Pujol J.P. Rhein inhibits interleukin-1b-induced activation of MEK\/ERK pathway and DNA binding of NF-kappa V and AP-1in chondrocytes cultured in hypoxia: potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation 2003; 27 (4): 233\u2014246.","DOI":"10.1023\/A:1025040631514"},{"key":"key-10.17116\/terarkh201587462-68-9","unstructured":"Pavelka K., Olejarova M., Rovensky J. Randomized, placebo-controlled Study of Diacerhein in painful osteoarthritis of the knee-assessment of carry-over effect. Ann Rheum Dis 2005; 64 (3): 483\u2014486."},{"key":"key-10.17116\/terarkh201587462-68-10","doi-asserted-by":"crossref","unstructured":"Martin G., Bogdanowicz P., Domagala F., Ficheux H., Pujol J.P. Rhein inhibits interleukin-1b-induced activation of MEK\/ERK pathway and DNA binding of NF-kappa V and AP-1in chondrocytes cultured in hypoxia: potential mechanism for its disease-modifying effect in osteoarthritis. Biorheology 2006; 43 (3\u20144): 577\u2014587.","DOI":"10.1177\/0006355X2006043003004040"},{"key":"key-10.17116\/terarkh201587462-68-11","doi-asserted-by":"crossref","unstructured":"Leeb B.F, Rintelen B. A Systematic meta-analysis trials with Diacerhein in osteoarthritis. Osteoarthritis cartilage 2005; 3 (Suppl A): 68.","DOI":"10.1016\/S1063-4584(05)80472-8"},{"key":"key-10.17116\/terarkh201587462-68-12","doi-asserted-by":"crossref","unstructured":"Curhan G.C., Knight E.L., Rosner B., Hankinson S.E., Stampfer\u00a0M.J. Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women. Arch Intern Med 2004; 164: 1519\u20141524.","DOI":"10.1001\/archinte.164.14.1519"},{"key":"key-10.17116\/terarkh201587462-68-13","doi-asserted-by":"crossref","unstructured":"Tall M.W., Brenner B.M. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int 2006; 70: 1694\u20141705.","DOI":"10.1038\/sj.ki.5001794"},{"key":"key-10.17116\/terarkh201587462-68-14","unstructured":"Shulutko B.I., Makarenko S.V. Tubulointerstitsial'nye vospalitel'nye zabolevaniya pochek. Nefrologiya 2004; 1: 89\u201497."},{"key":"key-10.17116\/terarkh201587462-68-15","unstructured":"Batyushin M.M., Terent'ev V.P., Dmitrieva O.V., Povilaite\u00a0P.E. Khronicheskaya bolezn' pochek: mesto nesteroidnykh protivovospalitel'nykh preparatov. Elista: Dzhangar 2009: 128."},{"key":"key-10.17116\/terarkh201587462-68-16","unstructured":"Androsova S.O., Fomin V.V., Shilov E.M. Tubulointerstitsial'nyi nefrit. V kn.: Nefrologiya. Natsional'noe rukovodstvo. M.: GEOTAR-Media 2009; 403\u2014411."},{"key":"key-10.17116\/terarkh201587462-68-17","unstructured":"Voronina N.V. Oksalatnaya nefropatiya. V kn.: Nefrologiya. Natsional'noe rukovodstvo. M.: GEOTAR-Media 2009; 412\u2014421."},{"key":"key-10.17116\/terarkh201587462-68-18","unstructured":"Ignatova M.S. Diagnostika i lechenie nefropatii s oksalatno-kal'tsievoi kristalluriei. V kn.: Nefrologiya. Rukovodstvo dlya vrachei. M.: Meditsina 2000; 354\u2014356."},{"key":"key-10.17116\/terarkh201587462-68-19","unstructured":"Yur'eva E.A., Korovina N.A., Kazanskaya i dr. Kliniko-biokhimicheskie aspekty interstitsial'nogo nefrita pri giperoksalurii. Vopr okhrany materinstva i detstva 1983; 8: 13\u201418."},{"key":"key-10.17116\/terarkh201587462-68-20","unstructured":"Voronina N.V., Gribovskaya N.V., Evseev A.N. Oksalatnaya nefropatiya: kliniko-morfologicheskie issledovaniya. Khabarovsk: izd-nie DVGMU 2014; 136."},{"key":"key-10.17116\/terarkh201587462-68-21","doi-asserted-by":"crossref","unstructured":"Ibanez L., Morlans M., Vidal X., Martinez M.J., Laporte J.-R. Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end- stage renal disease. Kidney Int 2005; 67: 2393\u20142398.","DOI":"10.1111\/j.1523-1755.2005.00346.x"},{"key":"key-10.17116\/terarkh201587462-68-22","doi-asserted-by":"crossref","unstructured":"Harris R.C. Cyclooxygenase-2 in the Kidney. J Am Soc Nephrol 2000; 11: 2387\u20142394.","DOI":"10.1681\/ASN.V11122387"},{"key":"key-10.17116\/terarkh201587462-68-23","unstructured":"Tareeva I.E., Mukhin N.A., Potapova A.V. Tubulointerstitsial'nye porazheniya pochek v nefrologicheskoi klinike. Klin med 1994; 1: 64\u201467."},{"key":"key-10.17116\/terarkh201587462-68-24","unstructured":"Shilov E., Androsova S.O. Lekarstvennye porazheniya pochek. Vrach 2002; 6: 47\u201449."},{"key":"key-10.17116\/terarkh201587462-68-25","unstructured":"Shulutko B.I. Nefrologiya-2002: sovremennoe sostoyanie problemy. SPb: Renkor 2002; 780."},{"key":"key-10.17116\/terarkh201587462-68-26","doi-asserted-by":"crossref","unstructured":"Breyer M.D., Hao C., Qi Z. Cyclooxygenase-2 selective inhibitors and the kidney. Curr Opin Crit Care 2001; 7 (6): 393\u2014400.","DOI":"10.1097\/00075198-200112000-00005"},{"key":"key-10.17116\/terarkh201587462-68-27","doi-asserted-by":"crossref","unstructured":"Deray G. Renal and cardiovascular effects of non-steroidal anti-inflammatories and selective, cox 2 inhibitors. Presse Med 2004; 7 (10): 483\u2014489.","DOI":"10.1016\/S0755-4982(04)98637-X"},{"key":"key-10.17116\/terarkh201587462-68-28","unstructured":"Galesic K., Moivvic-Vergles J., Jelakovic B. Nonsteroidal antirheumatics and the kidney. Reumatizam 2005; 52 (2): 61\u201466."},{"key":"key-10.17116\/terarkh201587462-68-29","doi-asserted-by":"crossref","unstructured":"Atmansori M.,Kovithavongs T., Oami M.U. Cyclooxygenase-2 inhibitor-associated minimal- change disease. Clin Nephrol 2005; 63 (5): 381\u2014384.","DOI":"10.5414\/CNP63381"},{"key":"key-10.17116\/terarkh201587462-68-30","unstructured":"Mukhin N.A., Tareeva I.E., Shilov E.M. Diagnostika i lechenie boleznei pochek. M.: GEOTAR-Med 2002: 384."},{"key":"key-10.17116\/terarkh201587462-68-31","unstructured":"Balkarov I.M., Lebedeva M.V., Shcherbak A.V., Mukhin N.A. Klinika, diagnostika i lechenie khronicheskogo tubulointerstitsial'nogo nefrita. Klin farmakologiya i terapiya 2000; 9 (5): 81\u201485."},{"key":"key-10.17116\/terarkh201587462-68-32","doi-asserted-by":"crossref","unstructured":"Perazella M.A. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003; 325 (6): 349\u2014362.","DOI":"10.1097\/00000441-200306000-00006"},{"key":"key-10.17116\/terarkh201587462-68-33","doi-asserted-by":"crossref","unstructured":"McAlindon T.E. et al. OARSI guidelines for non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage 2014; 22 (3): 363\u2014388.","DOI":"10.1016\/j.joca.2014.01.003"},{"key":"key-10.17116\/terarkh201587462-68-34","doi-asserted-by":"crossref","unstructured":"Dougados M., Nguyen M., Berdah L., Mazi\u00e9res B., Vignon E., Lequesne M.; ECHODIAH Investigators Study Group. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001; 44 (11): 2539\u20142547.","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T"},{"key":"key-10.17116\/terarkh201587462-68-35","unstructured":"A. V. Smirnov, E. M. Shilov, V. A. Dobronravov, I. G. Kayukov, I. N. Bobkova, M. Yu. Shvetsov, A. N. Tsygin, A. M. Shutov. Natsional'nye rekomendatsii. Khronicheskaya bolezn' pochek: osnovnye printsipy skrininga, diagnostiki, profilaktiki i podkhody k lecheniyu. Klinicheskaya nefrolgiya 2012;4: 4-26."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:33:42Z","timestamp":1748889222000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2015\/4\/downloads\/ru\/190040-366020150412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"alternative-id":["terarkh201587462-68"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201587462-68","relation":{},"ISSN":["0040-3660"],"issn-type":[{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2015]]}}}